Anzeige
Mehr »
Login
Donnerstag, 09.05.2024 Börsentäglich über 12.000 News von 688 internationalen Medien
Vor Neubewertung: Kupfer-Geheimtipp veröffentlich in dieser Sekunde sensationelle Bohrergebnisse
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
144 Leser
Artikel bewerten:
(0)

Dexcom Announces Release of Clarity Mobile App

EDINBURGH, October 11, 2018 /PRNewswire/ --

Mobile app allows patients to quickly access glucose data on their phone for diabetes management

Dexcom, Inc. (NASDAQ:DXCM), a leader in continuous glucose monitoring (CGM), announced today the release of the CLARITY mobile app.

(Logo: http://mma.prnewswire.com/media/553571/Dexcom_Logo.jpg )

The Dexcom CLARITY Diabetes Management Software is a cloud-based solution that simplifies CGM data reporting and facilitates the secure sharing of data between physicians and their patients. Now, with the CLARITY app, patients can view glucose insights with just a quick glance at their phone.

Key features on the app include:

  • Push notifications and summary emails delivering weekly insights directly to patients
  • Summary dashboard to view glucose metrics for selected time-period (7, 14, 30 and 90 days), including: time in range, estimated HbA1c (eHbA1c), average glucose and hypoglycaemia risk
  • Generate reports to save, print or email
  • Authorise data sharing between patient and clinic to make appointments more efficient

First launched for desktop, the Dexcom CLARITY diabetes management solution enables patients and clinics to review past glucose levels from the Dexcom CGM over user-defined time periods. Dexcom CLARITY offers a range of reports to meet varying user needs. Dexcom CLARITY's Overview report provides high-level metrics like estimated HbA1c and average glucose. CLARITY also compiles glucose trend data to identify patterns of hypoglycaemia (low blood sugar) and hyperglycaemia (high blood sugar). Dexcom CLARITY also has an Ambulatory Glucose Profile (AGP), a licensed, standardised glucose report created by the International Diabetes Center (IDC), that provides a big picture view of diabetes management.

The CLARITY app is compatible with iPhone, iPad, and iPod touch (requires iOS 10.3 or later) and any Android Device using OS version 6.0 or later. Please see here for full compatibility: https://www.dexcom.com/dexcom-international-compatibility.

The CLARITY app is now available in the following countries: Austria, Denmark, Finland, Germany, Hong Kong, Ireland, Luxembourg, Lebanon, Netherlands, Norway, Oman, Qatar, Sweden, Switzerland and the United Kingdom.

To review features and download from your app store, please visit here: https://clarity.dexcom.eu/mobile

About Dexcom, Inc.
Founded in 1999, Dexcom, Inc. has corporate offices in San Diego, California, EMEA headquarters in Edinburgh, Scotland and users in 39 countries around the world. At Dexcom, we are transforming diabetes care and management by providing superior continuous glucose monitoring (CGM) technology to help people with diabetes and healthcare professionals better manage diabetes. Since our inception, we have focused on better outcomes for people with diabetes, caregivers, and clinicians by delivering solutions that are best in class-while empowering our community to take control of diabetes. For more information on Dexcom CGM, visit http://www.dexcom.com/global.

Lithium vs. Palladium - Ist das die Chance des Jahrzehnts?
Sichern Sie sich den kostenlosen PDF-Report! So können Sie vom Boom der Rohstoffe profitieren.
Hier klicken
© 2018 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.